82 related articles for article (PubMed ID: 25064017)
1. A panel of biomarkers for predicting response to postoperative RT for laryngeal cancer?
Marioni G; Ottaviano G; Lionello M; Fasanaro E; Staffieri C; Giacomelli L; Gattazzo S; Staffieri A; Blandamura S
Am J Otolaryngol; 2014; 35(6):771-8. PubMed ID: 25064017
[TBL] [Abstract][Full Text] [Related]
2. Indications for postoperative radiotherapy in laryngeal carcinoma: a panel of tumor tissue markers for predicting locoregional recurrence in surgically treated carcinoma. A pilot study.
Marioni G; Blandamura S; Lionello M; Giacomelli L; Lovato A; Favaretto N; Breda S; Tealdo G; Guzzardo V; Ottaviano G; Staffieri A
Head Neck; 2014 Nov; 36(11):1534-40. PubMed ID: 23996283
[TBL] [Abstract][Full Text] [Related]
3. Elderly patients at higher risk of laryngeal carcinoma recurrence could be identified by a panel of two biomarkers (nm23-H1 and CD105) and pN+ status.
Lovato A; Marioni G; Manzato E; Staffieri C; Giacomelli L; Ralli G; Staffieri A; Blandamura S
Eur Arch Otorhinolaryngol; 2015 Nov; 272(11):3417-24. PubMed ID: 25280747
[TBL] [Abstract][Full Text] [Related]
4. Relationship between anti-apoptotic proteins survivin and Bcl-2, and response to treatment in patients undergoing post-operative RT for laryngeal cancer: a pilot study.
Marioni G; Staffieri A; Lionello M; Tealdo G; Staffieri C; Giacomelli L; Friso ML; Stramare R; Ottaviano G; Blandamura S
J Oral Pathol Med; 2013 Apr; 42(4):339-44. PubMed ID: 23126236
[TBL] [Abstract][Full Text] [Related]
5. High mTOR expression is associated with a worse oncological outcome in laryngeal carcinoma treated with postoperative radiotherapy: a pilot study.
Lionello M; Blandamura S; Loreggian L; Ottaviano G; Giacomelli L; Marchese-Ragona R; Velardita C; Staffieri A; Marioni G
J Oral Pathol Med; 2012 Feb; 41(2):136-40. PubMed ID: 21943204
[TBL] [Abstract][Full Text] [Related]
6. A prognostic role for Nm23-H1 in laryngeal carcinoma treated with postoperative radiotherapy: an introductory investigation.
Lionello M; Blandamura S; Agostini M; Staffieri C; Lovato A; Tealdo G; Favaretto N; Giacomelli L; Loreggian L; Staffieri A; Marioni G
Eur Arch Otorhinolaryngol; 2013 Jan; 270(1):197-203. PubMed ID: 23010793
[TBL] [Abstract][Full Text] [Related]
7. Neoangiogenesis in laryngeal carcinoma: angiogenin and CD105 expression is related to carcinoma recurrence rate and disease-free survival.
Marioni G; Marino F; Blandamura S; D'Alessandro E; Giacomelli L; Guzzardo V; Lionello M; De Filippis C; Staffieri A
Histopathology; 2010 Oct; 57(4):535-43. PubMed ID: 20955379
[TBL] [Abstract][Full Text] [Related]
8. Postoperative radiotherapy for laryngeal carcinoma: the prognostic role of subcellular Maspin expression.
Lionello M; Blandamura S; Staffieri C; Tealdo G; Giacomelli L; Marchese Ragona R; de Filippis C; Staffieri A; Marioni G
Am J Otolaryngol; 2015; 36(2):184-9. PubMed ID: 25459315
[TBL] [Abstract][Full Text] [Related]
9. Nuclear survivin expression correlates with endoglin-assessed microvascularisation in laryngeal carcinoma.
Marioni G; Ottaviano G; Marchese-Ragona R; Fasanaro E; Tealdo G; Zanotti C; Randon B; Giacomelli L; Stellini E; Blandamura S
J Clin Pathol; 2017 Dec; 70(12):1033-1037. PubMed ID: 28446541
[TBL] [Abstract][Full Text] [Related]
10. Biological tumor markers (maspin, CD105, nm23-H1) and disease relapse in laryngeal cancer: cluster analysis.
Franz L; Tealdo G; Contro G; Bandolin L; Carraro V; Giacomelli L; Alessandrini L; Blandamura S; Marioni G
Head Neck; 2020 Aug; 42(8):2129-2136. PubMed ID: 32212364
[TBL] [Abstract][Full Text] [Related]
11. A higher CD105-assessed microvessel density and worse prognosis in elderly patients with laryngeal carcinoma.
Marioni G; Staffieri A; Manzato E; Ralli G; Lionello M; Giacomelli L; Prosenikliev V; Marchese-Ragona R; Busnardo A; Bolzetta F; Blandamura S
Arch Otolaryngol Head Neck Surg; 2011 Feb; 137(2):175-80. PubMed ID: 21339405
[TBL] [Abstract][Full Text] [Related]
12. Laryngeal carcinoma prognosis after postoperative radiotherapy correlates with CD105 expression, but not with angiogenin or EGFR expression.
Marioni G; Blandamura S; Loreggian L; Koussis H; Lionello M; Giacomelli L; Fasanaro E; Lovato A; Staffieri A
Eur Arch Otorhinolaryngol; 2011 Dec; 268(12):1779-87. PubMed ID: 21842202
[TBL] [Abstract][Full Text] [Related]
13. A high nuclear nm23-H1 expression is associated with a better prognosis in elderly patients with laryngeal carcinoma.
Lionello M; Blandamura S; Lovato A; Franchella S; Giacomelli L; Ottaviano G; Stellini E; Staffieri A; Marioni G
Acta Otolaryngol; 2013 Aug; 133(8):874-80. PubMed ID: 23768014
[TBL] [Abstract][Full Text] [Related]
14. The EGFR-mTOR pathway and laryngeal cancer angiogenesis.
Lionello M; Lovato A; Staffieri A; Blandamura S; Turato C; Giacomelli L; Staffieri C; Marioni G
Eur Arch Otorhinolaryngol; 2014 Apr; 271(4):757-64. PubMed ID: 24065188
[TBL] [Abstract][Full Text] [Related]
15. Nuclear expression of onco-suppressors nm23-H1 and maspin are associated with lower recurrence rate in laryngeal carcinoma.
Marioni G; Ottaviano G; de Filippis C; Fasanaro E; Randon B; Meneghesso S; Giacomelli L; Astolfi L; Blandamura S
Am J Otolaryngol; 2019; 40(2):224-229. PubMed ID: 30683471
[TBL] [Abstract][Full Text] [Related]
16. mTOR expression and prognosis in elderly patients with laryngeal carcinoma: uni- and multivariate analyses.
Marioni G; Staffieri A; Lora L; Fermo S; Giacomelli L; La Torre FB; Favaretto N; Valentini E; Manzato E; Blandamura S
Oral Oncol; 2012 Jun; 48(6):530-4. PubMed ID: 22285859
[TBL] [Abstract][Full Text] [Related]
17. Nm23-H1 nuclear expression is associated with a more favourable prognosis in laryngeal carcinoma: univariate and multivariate analysis.
Marioni G; Ottaviano G; Lionello M; Lora L; Lovato A; Staffieri C; Favaretto N; Giacomelli L; Stellini E; Staffieri A; Blandamura S
Histopathology; 2012 Dec; 61(6):1057-64. PubMed ID: 22978449
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of hypoxia-inducible factors (angiogenin and endoglin) in open partial laryngectomies: uni- and multivariate analyses.
Marioni G; Staffieri A; Hagen R; Ottaviano G; Lionello M; Staffieri C; Giacomelli L; Blandamura S
Am J Otolaryngol; 2013; 34(1):3-9. PubMed ID: 22784587
[TBL] [Abstract][Full Text] [Related]
19. Clinical and pathological parameters prognostic for increased risk of recurrence after postoperative radiotherapy for temporal bone carcinoma.
Marioni G; Zanoletti E; Giacomelli L; Braggio L; Martini A; Mazzoni A
Head Neck; 2016 Jun; 38(6):894-8. PubMed ID: 26348213
[TBL] [Abstract][Full Text] [Related]
20. Rationale for adjuvant fatty acid therapy to prevent radiotherapy failure and tumor recurrence during early laryngeal squamous cell carcinoma.
Louw L; Claassen J
Prostaglandins Leukot Essent Fatty Acids; 2008 Jan; 78(1):21-6. PubMed ID: 18054475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
